Congratulations to Dr. Carolyn Baglole – featured in this week’s McGill Reporter as one of three Canadians receiving a grant from the Boehringer Ingelheim Innovation in Understanding Interstitial Lung Disease (BUILD) program, to support her research on idiopathic pulmonary fibrosis.
To read more about it, see:
http://publications.mcgill.ca/reporter/2017/04/build-grant-breathes-life...
Canada’s Minister of Environment and Climate Change, the Honourable Catherine McKenna announced a $50,000 grant from Natural Resources Canada’s Program for Energy Research and Development (PERD) to help TeamMTL participate in the international Solar Decathlon, to be held next year in Dezhou, China.
Researchers have identified the genetic mutation responsible for one patient's serious health problems, finally solving a medical mystery that has endured for over 30 years. Thanks to this discovery, the researcher developed a therapy that could also help a lot of people who have problems related to the immune system, whether they are genetic or due to a transplant or an illness.
With spring finally here and warmer temperatures just around the corner, snow will slowly melt away, releasing us from the clutches of winter. However, that’s not the only thing that the melting snow will release. Researchers from McGill University and École de technologie supérieure in Montreal have found that urban snow accumulates a toxic cocktail from car emissions - pollutants that are in turn unleashed into the environment as the weather warms up.
The ability to remember sounds, and manipulate them in our minds, is incredibly important to our daily lives — without it we would not be able to understand a sentence, or do simple arithmetic. New research is shedding light on how sound memory works in the brain, and is even demonstrating a means to improve it.
Dear members of the McGill community,
Professor Andrew Potter resigned from his position as Director of the McGill Institute for the Study of Canada (MISC). He made his letter of resignation public on social media.
I would like to acknowledge the contributions of Professor Potter and his courage in making this very difficult and painful decision.
Being diagnosed with a malignant brain tumor is devastating news for patients and their loved ones. Whereas some types of tumor respond well to treatment, others such as glioblastomas – the most common and aggressive brain tumors – are known to recur and progress within short times from the diagnosis. Patients diagnosed with this type of cancer, and who undergo current standard treatment, have a median survival of 16 months.
Congratulations to Necola Guerrina, our PhD student of Dr. Carolyn Baglole, who won second prize in the university-wide 3MT competition last week, for an outstanding presentation on her thesis research……
featured in the current issue of the McGill Reporter at http://publications.mcgill.ca/reporter/2017/03/three-minute-thesis-compe...
A multi-centre clinical study, led by Dr. Susan Kahn at the Jewish General Hospital (JGH), determined that nearly half of the patients who suffer a pulmonary embolism (PE) – a blood clot in the lung – experience long term limitations to their capacity for physical activity and that this had a negative impact on their quality of life. This research, published in Chest, is the first to demonstrate that PE may have a lasting effect on patients.
UPDATE: Thursday, 6:00 am
Back to business as usual today, after our very rare snow day. Students should consult with professors about rescheduled tests, exams, assignments and so on. Thanks to all staff who made it in yesterday. Now, let’s look forward to Spring!
-------
UPDATE: Wednesday, 10:45 am
Global migration has stirred questions of human rights, democracy, of living together, of ‘us and them.’ The philosopher Charles Taylor and the United Nations Special Rapporteur on the Human Rights of Migrants, and McGill law professor, François Crépeau, explore these and other questions at a time of rising populism and what may be called the fear of others.
Watch
Listen
Dr Morag Park, an associate member and research director for two of our PhD candidates in the department of Pathology, is the recipient of the Canadian Cancer Society 2017 Robert L. Noble Prize, as announced on March 8.
An acclaimed leader in Canadian cancer research, Dr. Park is widely recognized for her outstanding work in identifying key events in cancer development and the importance of tumour surroundings for cancer growth. She has also demonstrated exceptional leadership in establishing national cancer research strategies as acknowledged by the Canadian Cancer Society.
